NVST240920P15000
- 0.10
- 0.000.00%
Envista Holdings Newsroom
Analysts Offer Insights on Healthcare Companies: Pyxis Oncology (PYXS), Spruce Biosciences (SPRB) and Envista Holdings (NVST)
DEXIS Launches DEXIS Connect Pro, a New Proactive Service Platform for DEXIS CBCT and Intraoral Sensor Devices, Focused on Increasing Device Uptime
Insider Buying: CEO Paul Keel Acquires Shares of Envista Holdings Corp (NVST)
Insider Buying: CFO Eric Hammes Acquires Shares of Envista Holdings Corp (NVST)
Maintaining Hold on Envista Holdings Amid Financial Challenges and Uncertain Recovery
Is Now An Opportune Moment To Examine Envista Holdings Corporation (NYSE:NVST)?
Envista Holdings: Sell Rating Justified by Poor Q2 Performance and Negative FY24 Guidance
Evaluating Envista Holdings: Insights From 7 Financial Analysts
Envista Holdings Price Target Cut to $19.00/Share From $22.00 by B of A Securities
Envista Holdings Is Maintained at Buy by B of A Securities
Envista (NVST) Q2 Earnings & Revenues Miss, Margins Fall
Evercore ISI Group Maintains Outperform on Envista Holdings, Lowers Price Target to $18
Envista Holdings (NVST) Receives a Hold From Piper Sandler
Analysts Offer Insights on Healthcare Companies: MannKind (MNKD), Envista Holdings (NVST) and Soleno Therapeutics (SLNO)
Express News | JP Morgan Downgrades Envista Holdings to Neutral, Lowers Price Target to $16
Express News | Envista Holdings Shares Are Trading Lower Following Worse-than-expected Q2 Financial Results
Express News | Envista Holdings Corp : JP Morgan Cuts to Neutral From Overweight
Express News | Needham Reiterates Hold on Envista Holdings
Envista Holdings Analyst Ratings
Envista Holdings: A Cautious Hold Amidst Transition and Anticipated Strategic Insights